These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 1264671

  • 1. [Letter: Efficacy of bromocriptine in 2 cases of levodopa-resistant parkinsonism].
    Kissel P, Andre JM, Jacquier A.
    Nouv Presse Med; 1976 Jan 24; 5(4):210. PubMed ID: 1264671
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Letter: Bromocriptine in parkinsonism.
    Debono AG, Donaldson I, Marsden CD, Parkes JD.
    Lancet; 1975 Nov 15; 2(7942):987-8. PubMed ID: 53479
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparison between lergotrile and bromocriptine in parkinsonism.
    Teychenne PF, Pfeiffer RF, Bern SM, McInturff D, Calne DB.
    Ann Neurol; 1978 Apr 15; 3(4):319-24. PubMed ID: 666273
    [Abstract] [Full Text] [Related]

  • 6. Clinical studies with bromocriptine in idiopathic parkinsonism.
    Teychenne PF, Kartzinel R, Perlow M, Pfeiffer R, Calne DB.
    Trans Am Neurol Assoc; 1976 Apr 15; 101():302-4. PubMed ID: 1037483
    [No Abstract] [Full Text] [Related]

  • 7. [Oral lisuride in Parkinson's disease].
    Obeso JA, Luquin MR, Martínez Lage JM.
    Med Clin (Barc); 1985 Sep 21; 85(8):307-12. PubMed ID: 4068822
    [No Abstract] [Full Text] [Related]

  • 8. [Clinical experience with bromocriptine, a central dopaminergic stimulator].
    Ludin HP, Kunz F, Lörincz P, Ringwald E.
    Nervenarzt; 1976 Nov 21; 47(11):651-5. PubMed ID: 794749
    [No Abstract] [Full Text] [Related]

  • 9. Studies with bromocriptine. Part 2. Double-blind comparison with levodopa in idiopathic parkinsonism.
    Kartzinel R, Shoulson I, Calne DB.
    Neurology; 1976 Jun 21; 26(6 PT 1):511-3. PubMed ID: 778655
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Letter: Bromocriptine in parkinsonism.
    Lees AJ, Shaw KM, Stern GM.
    Lancet; 1975 Oct 11; 2(7937):709-10. PubMed ID: 52084
    [No Abstract] [Full Text] [Related]

  • 13. Comparative efficacy of pergolide and bromocriptine in patients with advanced Parkinson's disease.
    Lieberman AN, Neophytides A, Leibowitz M, Gopinathan G, Pact V, Walker R, Goodgold A, Goldstein M.
    Adv Neurol; 1983 Oct 11; 37():95-108. PubMed ID: 6858782
    [Abstract] [Full Text] [Related]

  • 14. Studies with bromocriptine. Part 1. "On-off" phenomena.
    Kartznel R, Calne DB.
    Neurology; 1976 Jun 11; 26(6 PT 1):508-10. PubMed ID: 945489
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparison of the effects of bromocriptine and levodopa in Parkinson's disease.
    Godwin-Austen RB, Smith NJ.
    J Neurol Neurosurg Psychiatry; 1977 May 11; 40(5):479-82. PubMed ID: 330825
    [Abstract] [Full Text] [Related]

  • 18. [Treatment of parkinsonism with dopaminergic system agonists].
    Dowzenko A.
    Neurol Neurochir Pol; 1976 May 11; 10(4):579-82. PubMed ID: 958587
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Developments in the treatment of parkinsonism.
    Calne DB.
    N Engl J Med; 1976 Dec 16; 295(25):1433-4. PubMed ID: 989886
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.